Digitotalar dysmorphism: Molecular elucidation by Vorster, Anna Alvera et al.
IN PRACTICE
253       March 2016, Vol. 106, No. 3
Dominantly inherited digitotalar dysmorphism (DTD), which is characterised by flexion contractures of digits and ‘rocker-bottom’ feet 
due to a vertical talus, was first described in a South African family of European stock in 1972. We review the clinical manifestations and 
document the molecular basis for DTD in this prototype family. This family was restudied in 1995 and 2006 and biological specimens were 
obtained for molecular studies. Since the distal arthrogryposes (DAs) are genetically heterogeneous, an unbiased approach to mutation 
identification was undertaken through whole-exome next-generation sequencing of DNA from a single DTD-affected female. Venous blood 
specimens were obtained for DNA banking and subsequent molecular studies. Analysis of the nine genes that had previously been shown to 
cause DAs revealed a pathogenic mutation in exon nine of TNNT3. The presence of the p.(Arg63His) missense mutation at position 63 of 
TNNT3 was confirmed through direct cycle sequencing of genomic DNA in six affected family members for whom DNA had been archived.
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Background
Digitotalar dysmorphism (DTD; OMIM #126050) 
is an autosomal dominant disorder characterised by 
congenital fixed flexion deformities of the digits and 
‘rocker-bottom’ feet due to a vertical position of the 
talus. The condition was originally delineated more than 40 years ago 
in five generations of a large South African (SA) kindred of European 
stock.[1]
The distal arthrogryposes (DAs) are a group of genetic disorders 
in which congenital contractures in the hands and feet are the main 
manifestations.[2] The individual members of the DA category have 
numerical designations 1 - 10, with subtypes indicated by letters in 
some instances. A few well-known eponymous genetic disorders with 
contractures plus craniofacial involvement have also been listed as 
DAs.
With ongoing elucidation of the molecular basis of the DAs, several 
genes that encode the contractile apparatus of the fast-twitch 
myofibrils have been implicated.[3] It has also emerged that there 
is considerable molecular heterogeneity in the DAs and that some 
conditions regarded as having autonomous syndromic status have 
identical mutational determinants.[4,5]
The prototype DTD family was restudied in 1995 and 2006, 
and biological specimens were obtained for molecular studies. A 
causative mutation in the TNNT3 (OMIM #600692) gene has now 
been identified.
The affected family
The proposita of the DTD family was born in SA in 1916 and initially 
examined in 1971 at the age of 55 years. At that time, nine affected 
persons in three generations were available for documentation. 
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Family photographs revealed that deceased individuals in two 
preceding generations had the disorder. The pedigree data were in 
keeping with autosomal dominant inheritance, with some variability 
in phenotypic expression and complete penetrance. The progenitor 
of the kindred had emigrated from Holland to SA during the 18th 
century, and there could be additional affected persons in the 
extended family in Europe.
The kindred was restudied in 1995 and in 2006, by which time 
three affected children in a new generation had been born and 11 
affected persons in four generations were alive. Biological specimens 
for molecular investigations were obtained.
Clinical manifestations
The clinical manifestations in nine affected family members have 
been documented and depicted in the orthopaedic literature.[1] The 
main syndromic components are rigidities of the digits in the hands 
and feet together with vertical alignment of the talus bones in the 
ankles. Involvement of the extremities is usually bilateral and not 
necessarily symmetrical or of equal severity.
Hands
Flexion contracture of the digits, with some ulnar deviation, are 
consistent features. Severity and distribution are variable, but the 
deformities are fixed and neither progress nor ameliorate. The 
thumbs may lie in opposition, internal rotation movements being 
limited by a fleshy web. The soft tissues of the middle phalanges 
are attenuated, producing an appearance of digital narrowing 
and tightness of the overlying skin. The ventral surfaces of the 
fingers and palms are smooth with few markings, and a single 
palmar crease may be present. There is no evidence of vascular or 
neurological deficit, and the degree of physical handicap is usually 
mild. Radiological examination shows that the bones of the hands 
are entirely normal.
Feet
In the feet, vertical angulation of the talus bone is an important 
diagnostic manifestation which was present in 10 of the 12 family 
members for whom clinical information was available. This 
malpositioning produces the well-known ‘rocker-bottom’ convex 
configuration of the soles. The forefeet may be wide and flat with 
medial bulging of the insteps and flexion of the toes. As with the 
hands, the severity of involvement of the feet is variable. At the severe 
end of the spectrum, the fitting of shoes may be difficult and operative 
intervention may be required to facilitate ambulation.
Other manifestations
General health and intellectual function are normal, as are the facies, 
teeth, hair, nails, viscera and other bodily systems. Stature is normal for 
the generation and population group of the affected persons. The range 
of movements in the wrist, ankles and knees is limited to some extent 
in a minority of affected family members. In recent years two affected 
women have had caesarean sections for childbirth; the obstetric 
indications for these procedures are not known. Two family members 
have had bilateral carpal tunnel release operations in the wrists.
Methods
The family was reviewed in 1995 and again in 2006 when members 
of the new generation were examined and venous blood specimens 
were obtained for DNA banking and subsequent molecular studies. 
The specimens were collected with full signed consent, in accordance 
with established procedure.
Genomic DNA (gDNA) was extracted from peripheral blood 
lymphocytes using the salting-out method[6] and archived for 11 
family members, of whom six had the classic DTD phenotype. For the 
identification of the disease-causing variant, whole-exome sequencing 
was performed for one patient (DTD1.3ISA) on the Illumina HiSeq 
2000 (Illumina Inc., USA) using the NimbleGen V2 exome kit (Roche 
Fig. 1. Pedigree structure of relevant family members and direct cycle sequencing results for exon nine of TNNT3. Square symbols represent males, and circles 
females. Blackened symbols represent family members who are affected with DTD. The arrows in the electropherograms denote the c.188G>A; p.(Arg63His) 
mutation in exon 9 of TNNT3, which was present in all six affected family members who were sequenced. The mutation was not identified in two spouses 
(DTD1.4GER and DTD1.11PEM) or in three unaffected siblings (DTD1.2EVE, DTD1.7GLO and DTD1.9LIZ).
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NimbleGen Inc., USA) for capture. A mean coverage of 34.5 times 
was achieved across all targeted bases to enable whole-exome variant 
calling. The variants identified in DTD1.3ISA were filtered for known 
pathogenic mutations from the ClinVar database[7,8] in nine genes 
(TPM2, MYBPC1, MYH3, TNNT3, TNNI2, PIEZO2, ECEL1, MYH8 
and FBN2) that had previously been shown to be mutated in persons 
with DA (OMIM #108120).
To validate the pathogenic variant identified through whole-exome 
sequencing analysis of DTD1.3ISA, 100 ng of gDNA was amplified 
for exon nine of TNNT3 (RefSeq NM_006757.3) using 0.4 µM each 
of the sense (5´-CATGGCAATGTGGAGAAG-3´) and antisense 
(5´-CTCTGATGAGGCAGCAGT-3´) primers in a final polymerase chain 
reaction (PCR) volume of 25 µl containing 0.5 U GoTaq DNA polymerase, 
1 × colourless reaction buffer (Promega, USA) and 0.2 mM of each 
deoxynucleoside triphosphate (Bioline, UK). Following 5 minutes of 
denaturation at 95°C on the BioRad T100 thermal cycler (Bio-Rad, USA), 
DNA was amplified in 35 cycles of denaturation at 94°C for 30 seconds, 
with primer annealing at 60°C for 30 seconds and product extension at 
72°C for 40 seconds. The reaction was concluded at 72°C for 7 minutes 
to allow for complete product extension. Direct cycle sequencing of the 
resulting fragments was completed using 0.08 µM of primers described for 
PCR with the BigDye direct cycle sequencing chemistry (Life Technologies, 
USA) on the 3130xl Genetic Analyser (Applied Biosystems, USA). DNA 
sequences of research participants were aligned to the reference TNNT3 
(NG_013085.1) sequence using Unipro UGENE v1.14.2.[9]
This investigation received ethical approval from the UCT Faculty of 
Health Sciences Human Research Ethics Committee (REC REF 917/2014).
Results
Following whole-exome sequencing analysis of a person with DTD, 
102 nucleotide variants were identified within the nine known genes 
that cause DAs. Twenty-one of these variants were described in 
the ClinVar database, and only one had a pathogenic designation 
(RCV000009468). The pathogenic variant, identified in TNNT3 
(NM_006757.3), is a transition mutation at position 188 of the 
consensus coding sequence and is predicted to substitute an arginine 
for a histidine residue at amino acid position 63.
The presence of the c.188G>A mutation in the gDNA of 
DTD1.3ISA was confirmed through direct cycle sequencing of exon 
9 of TNNT3 (Fig. 1, DTD1.3ISA). Following direct cycle sequencing 
of exon nine of TNNT3 in 10 extended-family members for whom 
DNA was archived, all affected individuals (n=6) were shown to carry 
the variant allele, while neither of the spouses (n=2) and none of the 
unaffected members (n=3) inherited the c.188G>A mutation.
Discussion
The prototype SA family with DTD is regarded as having a form of 
DA, and the vertical talus bones that produce the ‘rocker-bottom’ 
feet are a prime syndromic component.[1] In addition to DTD, 
a congenital vertical talus can occur sporadically and as a non-
syndromic autosomal dominant trait.[10,11]
The issue of syndromic identity arose when a form of DTD 
associated with craniofacial abnormalities was documented.[12] 
In a series of 47 families with either DA2A or DA2B, Sung et 
al.[13] identified the TNNT3 c.188G>A; p.(Arg63His) mutation in a 
mother and her two DA2B-affected children. Specific phenotypic 
description was not provided for the family. The Sheldon-Hall type 
of DA also manifests significant facial features and a vertical talus; 
considerable non-allelic heterogeneity was demonstrated in this 
condition, including mutations in the gene TNNT3.[3] Thereafter, in 
2011, Zhao et al.[14] documented five members of three generations of 
a Chinese family with the Sheldon-Hall phenotype and demonstrated 
that they had a specific mutation in TNNT3 (c.187C>T; p.R63C). 
These authors suggested that bilateral vertical talus or clubfoot might 
be a special characteristic of this hot-spot mutation. The TNNT3 
mutation, reported by Sung et al.[13] in 2003, has now been identified 
in the prototype DTD family in SA. It is relevant that the craniofacial 
structures are entirely normal in this SA kindred, and the reason for 
the disparity in the genotype-phenotype correlation is unknown. 
Nevertheless, the recognition of a vertical talus as an indicator of a 
specific mutation is a useful concept.[13]
From the clinical standpoint, the detection of the specific TNNT3 
mutation in the SA DTD family will facilitate genetic management. 
These measures could include diagnostic confirmation, antenatal 
diagnosis and genetic counselling, among others. In the future, 
the elucidation of the role of the causative TNNT3 mutation in the 
pathogenesis of DTD could have implications for targeted forms of 
therapy.
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